259 related articles for article (PubMed ID: 35215337)
1. Experimental Nuclear Medicine Meets Tumor Biology.
Balber T; Tran L; Benčurová K; Raitanen J; Egger G; Mitterhauser M
Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215337
[TBL] [Abstract][Full Text] [Related]
2. The role of the toxicologic pathologist in the post-genomic era(#).
Maronpot RR
J Toxicol Pathol; 2013 Jun; 26(2):105-10. PubMed ID: 23914052
[TBL] [Abstract][Full Text] [Related]
3. Translational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug Discovery.
Hosoya M; Czysz K
Cells; 2016 Dec; 5(4):. PubMed ID: 28009813
[TBL] [Abstract][Full Text] [Related]
4. Personalized translational epilepsy research - Novel approaches and future perspectives: Part II: Experimental and translational approaches.
Bauer S; van Alphen N; Becker A; Chiocchetti A; Deichmann R; Deller T; Freiman T; Freitag CM; Gehrig J; Hermsen AM; Jedlicka P; Kell C; Klein KM; Knake S; Kullmann DM; Liebner S; Norwood BA; Omigie D; Plate K; Reif A; Reif PS; Reiss Y; Roeper J; Ronellenfitsch MW; Schorge S; Schratt G; Schwarzacher SW; Steinbach JP; Strzelczyk A; Triesch J; Wagner M; Walker MC; von Wegner F; Rosenow F
Epilepsy Behav; 2017 Nov; 76():7-12. PubMed ID: 28917498
[TBL] [Abstract][Full Text] [Related]
5. General overview: biomarkers in neuroscience research.
Filiou MD; Turck CW
Int Rev Neurobiol; 2011; 101():1-17. PubMed ID: 22050846
[TBL] [Abstract][Full Text] [Related]
6. Advancing translational research and precision medicine with targeted proteomics.
Uzozie AC; Aebersold R
J Proteomics; 2018 Oct; 189():1-10. PubMed ID: 29476807
[TBL] [Abstract][Full Text] [Related]
7. Impact of Biomarkers on Personalized Medicine.
Carrigan P; Krahn T
Handb Exp Pharmacol; 2016; 232():285-311. PubMed ID: 26330258
[TBL] [Abstract][Full Text] [Related]
8. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
Amacher DE
Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
[TBL] [Abstract][Full Text] [Related]
9. Biomarker-driven early clinical trials in oncology: a paradigm shift in drug development.
Tan DS; Thomas GV; Garrett MD; Banerji U; de Bono JS; Kaye SB; Workman P
Cancer J; 2009; 15(5):406-20. PubMed ID: 19826361
[TBL] [Abstract][Full Text] [Related]
10. Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment.
Phan JH; Moffitt RA; Stokes TH; Liu J; Young AN; Nie S; Wang MD
Trends Biotechnol; 2009 Jun; 27(6):350-8. PubMed ID: 19409634
[TBL] [Abstract][Full Text] [Related]
11. Data-driven translational prostate cancer research: from biomarker discovery to clinical decision.
Lin Y; Zhao X; Miao Z; Ling Z; Wei X; Pu J; Hou J; Shen B
J Transl Med; 2020 Mar; 18(1):119. PubMed ID: 32143723
[TBL] [Abstract][Full Text] [Related]
12. The acute respiratory distress syndrome biomarker pipeline: crippling gaps between discovery and clinical utility.
Bime C; Camp SM; Casanova N; Oita RC; Ndukum J; Lynn H; Garcia JGN
Transl Res; 2020 Dec; 226():105-115. PubMed ID: 32599095
[TBL] [Abstract][Full Text] [Related]
13. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
Høilund-Carlsen PF
Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
[TBL] [Abstract][Full Text] [Related]
14. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
de Wit M; Fijneman RJ; Verheul HM; Meijer GA; Jimenez CR
Clin Biochem; 2013 Apr; 46(6):466-79. PubMed ID: 23159294
[TBL] [Abstract][Full Text] [Related]
15. Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer.
Zhang L; Xiao H; Karlan S; Zhou H; Gross J; Elashoff D; Akin D; Yan X; Chia D; Karlan B; Wong DT
PLoS One; 2010 Dec; 5(12):e15573. PubMed ID: 21217834
[TBL] [Abstract][Full Text] [Related]
16. Cancer Biomarkers Discovery and Validation: State of the Art, Problems and Future Perspectives.
Mordente A; Meucci E; Martorana GE; Silvestrini A
Adv Exp Med Biol; 2015; 867():9-26. PubMed ID: 26530357
[TBL] [Abstract][Full Text] [Related]
17. Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies.
Starmans MH; Pintilie M; John T; Der SD; Shepherd FA; Jurisica I; Lambin P; Tsao MS; Boutros PC
Genome Med; 2012; 4(11):84. PubMed ID: 23146350
[TBL] [Abstract][Full Text] [Related]
18. A caspase-3 'death-switch' in colorectal cancer cells for induced and synchronous tumor apoptosis in vitro and in vivo facilitates the development of minimally invasive cell death biomarkers.
Simpson KL; Cawthorne C; Zhou C; Hodgkinson CL; Walker MJ; Trapani F; Kadirvel M; Brown G; Dawson MJ; MacFarlane M; Williams KJ; Whetton AD; Dive C
Cell Death Dis; 2013 May; 4(5):e613. PubMed ID: 23640455
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
